Analysis of eplerenone in the FDA adverse event reporting system (FAERS) database: a focus on overall patient population and gender-specific subgroups

Introduction: Eplerenone is approved for the treatment of hypertension as well as symptomatic heart failure with reduced ejection fraction (HFrEF) following an acute myocardial infarction. However, the adverse events (AEs) have not been systematically analyzed. The aim of this study was to identify...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Xin Guan (Verfasst von), Yusi Yang (Verfasst von), Xinru Li (Verfasst von), Yue Feng (Verfasst von), Jizhen Li (Verfasst von), Xuewen Li (Verfasst von)
Format: Buch
Veröffentlicht: Frontiers Media S.A., 2024-07-01T00:00:00Z.
Schlagworte:
Online-Zugang:Connect to this object online.
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Online

Connect to this object online.

3rd Floor Main Library

Bestandsangaben von 3rd Floor Main Library
Signatur: A1234.567
Exemplar 1 Verfügbar